These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7513912

  • 1. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.
    Cvetkovic M, Mann GN, Romero DF, Liang XG, Ma Y, Jee WS, Epstein S.
    Transplantation; 1994 Apr 27; 57(8):1231-7. PubMed ID: 7513912
    [Abstract] [Full Text] [Related]

  • 2. Evidence that cyclosporine G is less deleterious to rat bone in vivo than cyclosporine A.
    Stein B, Takizawa M, Schlosberg M, Movsowitz C, Fallon M, Berlin JA, Epstein S.
    Transplantation; 1992 Mar 27; 53(3):628-32. PubMed ID: 1549857
    [Abstract] [Full Text] [Related]

  • 3. The role of testosterone in cyclosporine-induced osteopenia.
    Bowman AR, Sass DA, Dissanayake IR, Ma YF, Liang H, Yuan Z, Jee WS, Epstein S.
    J Bone Miner Res; 1997 Apr 27; 12(4):607-15. PubMed ID: 9101372
    [Abstract] [Full Text] [Related]

  • 4. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S, Takizawa M, Stein B, Katz IA, Joffe II, Romero DF, Liang XG, Li M, Ke HZ, Jee WS.
    J Bone Miner Res; 1994 Apr 27; 9(4):557-66. PubMed ID: 8030444
    [Abstract] [Full Text] [Related]

  • 5. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
    Sass DA, Bowman AR, Yuan Z, Ma Y, Jee WS, Epstein S.
    Bone; 1997 Jul 27; 21(1):65-70. PubMed ID: 9213009
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
    Epstein S, Schlosberg M, Fallon M, Thomas S, Movsowitz C, Ismail F.
    Calcif Tissue Int; 1990 Sep 27; 47(3):152-7. PubMed ID: 2224590
    [Abstract] [Full Text] [Related]

  • 9. Utilization of cyclosporine H to elucidate the possible mechanisms of cyclosporine A-induced osteopenia in the rat.
    Rucinski B, Liu CC, Epstein S.
    Metabolism; 1994 Sep 27; 43(9):1114-8. PubMed ID: 8084286
    [Abstract] [Full Text] [Related]

  • 10. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
    Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S.
    J Lab Clin Med; 1990 Jan 27; 115(1):62-8. PubMed ID: 2299257
    [Abstract] [Full Text] [Related]

  • 11. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
    Bryer HP, Isserow JA, Armstrong EC, Mann GN, Rucinski B, Buchinsky FJ, Romero DF, Epstein S.
    J Bone Miner Res; 1995 Jan 27; 10(1):132-8. PubMed ID: 7747620
    [Abstract] [Full Text] [Related]

  • 12. Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment.
    Sass DA, Rucinski B, Bryer HP, Mann GN, Yuan Z, Ma Y, Jee WS, Epstein S.
    Bone; 1996 Oct 27; 19(4):381-6. PubMed ID: 8894144
    [Abstract] [Full Text] [Related]

  • 13. Rapamycin: a bone sparing immunosuppressant?
    Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, Ma YF, Jee WS, Epstein S.
    J Bone Miner Res; 1995 May 27; 10(5):760-8. PubMed ID: 7543725
    [Abstract] [Full Text] [Related]

  • 14. Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat.
    Mann GN, Sass DA, Chen HK, Buchinsky FJ, Bryer HP, Ma YF, Jee WS, Rucinski B, Epstein S.
    Calcif Tissue Int; 1996 Jul 27; 59(1):38-44. PubMed ID: 8661983
    [Abstract] [Full Text] [Related]

  • 15. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
    Katz I, Li M, Joffe I, Stein B, Jacobs T, Liang XG, Ke HZ, Jee W, Epstein S.
    J Bone Miner Res; 1994 Jan 27; 9(1):59-67. PubMed ID: 8154310
    [Abstract] [Full Text] [Related]

  • 16. Structural skeletal impairment induced by immunosuppressive therapy in rats: cyclosporine A vs tacrolimus.
    Abdelhadi M, Ericzon BG, Hultenby K, Sjöden G, Reinholt FP, Nordenström J.
    Transpl Int; 2002 Apr 27; 15(4):180-7. PubMed ID: 11976740
    [Abstract] [Full Text] [Related]

  • 17. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
    Epstein S, Dissanayake IR, Goodman GR, Bowman AR, Zhou H, Ma Y, Jee WS.
    Calcif Tissue Int; 2001 Apr 27; 68(4):240-7. PubMed ID: 11353952
    [Abstract] [Full Text] [Related]

  • 18. Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats.
    Inoue T, Kawamura I, Matsuo M, Aketa M, Mabuchi M, Seki J, Goto T.
    Transplantation; 2000 Sep 15; 70(5):774-9. PubMed ID: 11003356
    [Abstract] [Full Text] [Related]

  • 19. Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption.
    Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S.
    J Bone Miner Res; 1989 Jun 15; 4(3):393-8. PubMed ID: 2788358
    [Abstract] [Full Text] [Related]

  • 20. 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
    Joffe I, Katz I, Jacobs T, Stein B, Takizawa M, Liu C, Berlin J, Epstein S.
    Endocrinology; 1992 Mar 15; 130(3):1578-86. PubMed ID: 1537307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.